| 1 |
Almasi F, Dang W, Mohammadipanah F, Li N. Neurological disorders of COVID-19: insights to applications of natural products from plants and microorganisms. Arch Pharm Res 2022. [DOI: 10.1007/s12272-022-01420-3] [Reference Citation Analysis]
|
| 2 |
Heimke M, Lenz F, Rickert U, Lucius R, Cossais F. Anti-Inflammatory Properties of the SGLT2 Inhibitor Empagliflozin in Activated Primary Microglia. Cells 2022;11:3107. [PMID: 36231069 DOI: 10.3390/cells11193107] [Reference Citation Analysis]
|
| 3 |
Sun Q, Xu W, Piao J, Su J, Ge T, Cui R, Yang W, Li B. Transcription factors are potential therapeutic targets in epilepsy. J Cell Mol Med 2022. [PMID: 36065764 DOI: 10.1111/jcmm.17518] [Reference Citation Analysis]
|
| 4 |
Salgado-benvindo C, Leijs AA, Thaler M, Tas A, Arbiser JL, Snijder EJ, van Hemert MJ. Honokiol inhibits SARS-CoV-2 replication in cell culture.. [DOI: 10.1101/2022.07.26.501656] [Reference Citation Analysis]
|
| 5 |
Wang Y, Wu P, Liu F, Chen J, Xue J, Qin Y, Chen F, Wang S, Ji L. Design, synthesis, and biological evaluation of membrane-active honokiol derivatives as potent antibacterial agents. Eur J Med Chem 2022;240:114593. [PMID: 35820350 DOI: 10.1016/j.ejmech.2022.114593] [Reference Citation Analysis]
|
| 6 |
Zhu S, Liu F, Zhang R, Xiong Z, Zhang Q, Hao L, Chen S. Neuroprotective Potency of Neolignans in Magnolia officinalis Cortex Against Brain Disorders. Front Pharmacol 2022;13:857449. [DOI: 10.3389/fphar.2022.857449] [Reference Citation Analysis]
|
| 7 |
Ren Z, Lv M, Zhang Y, Li T, Xu H. High Value-Added Application of Natural Plant Products in Crop Protection: Honokiol Monoester/Diester Derivatives Containing the Novel Core Scaffold of Benzodihydrofuran and Their Agricultural Bioactivities and Control Effects. J Agric Food Chem 2022;70:5319-29. [PMID: 35441514 DOI: 10.1021/acs.jafc.1c08292] [Reference Citation Analysis]
|
| 8 |
Liu Y, Zhou J, Luo Y, Li J, Shang L, Zhou F, Yang S. Honokiol alleviates LPS-induced acute lung injury by inhibiting NLRP3 inflammasome-mediated pyroptosis via Nrf2 activation in vitro and in vivo. Chin Med 2021;16:127. [PMID: 34844623 DOI: 10.1186/s13020-021-00541-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 9 |
Chen W, Wu J, Zhan S, Lu X. Honokiol inhibits endoplasmic reticulum stress-associated lipopolysaccharide-induced inflammation and apoptosis in bovine endometrial epithelial cells. Exp Ther Med 2021;22:1476. [PMID: 34765017 DOI: 10.3892/etm.2021.10911] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Vaulina DD, Stosman KI, Sivak KV, Aleksandrov AG, Viktorov NB, Kuzmich NN, Kiseleva MM, Kuznetsova OF, Gomzina NA. Preliminary Assessment of the Anti-inflammatory Activity of New Structural Honokiol Analogs with a 4'-O-(2-Fluoroethyl) Moiety and the Potential of Their 18F-Labeled Derivatives for Neuroinflammation Imaging. Molecules 2021;26:6630. [PMID: 34771039 DOI: 10.3390/molecules26216630] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 11 |
Nie W, Ding L, Lei T, Liu Z, Li J, Song L, Wu X. Biphenyl-type neolignans with NO inhibitory activity from the fruits of Magnolia tripetala. Phytochemistry Letters 2021;44:222-6. [DOI: 10.1016/j.phytol.2021.06.026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Rauf A, Olatunde A, Imran M, Alhumaydhi FA, Aljohani ASM, Khan SA, Uddin MS, Mitra S, Emran TB, Khayrullin M, Rebezov M, Kamal MA, Shariati MA. Honokiol: A review of its pharmacological potential and therapeutic insights. Phytomedicine 2021;90:153647. [PMID: 34362632 DOI: 10.1016/j.phymed.2021.153647] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 13.5] [Reference Citation Analysis]
|
| 13 |
Govindarajulu M, Ramesh S, Neel L, Fabbrini M, Buabeid M, Fujihashi A, Dwyer D, Lynd T, Shah K, Mohanakumar KP, Smith F, Moore T, Dhanasekaran M. Nutraceutical based SIRT3 activators as therapeutic targets in Alzheimer's disease. Neurochem Int 2021;144:104958. [PMID: 33444675 DOI: 10.1016/j.neuint.2021.104958] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 14 |
Zhu S, Chen P, Chen Y, Li M, Chen C, Lu H. 3D-Printed Extracellular Matrix/Polyethylene Glycol Diacrylate Hydrogel Incorporating the Anti-inflammatory Phytomolecule Honokiol for Regeneration of Osteochondral Defects. Am J Sports Med 2020;48:2808-18. [PMID: 32762553 DOI: 10.1177/0363546520941842] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 10.7] [Reference Citation Analysis]
|
| 15 |
Bai Y, Ma X. Chlorzoxazone exhibits neuroprotection against Alzheimer's disease by attenuating neuroinflammation and neurodegeneration in vitro and in vivo. Int Immunopharmacol 2020;88:106790. [PMID: 32795892 DOI: 10.1016/j.intimp.2020.106790] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 16 |
Zhang GZ, Deng YJ, Xie QQ, Ren EH, Ma ZJ, He XG, Gao YC, Kang XW. Sirtuins and intervertebral disc degeneration: Roles in inflammation, oxidative stress, and mitochondrial function. Clin Chim Acta 2020;508:33-42. [PMID: 32348785 DOI: 10.1016/j.cca.2020.04.016] [Cited by in Crossref: 42] [Cited by in F6Publishing: 46] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 17 |
Hsiao YP, Chen HT, Liang YC, Wang TE, Huang KH, Hsu CC, Liang HJ, Huang CH, Jan TR. Development of Nanosome-Encapsulated Honokiol for Intravenous Therapy Against Experimental Autoimmune Encephalomyelitis. Int J Nanomedicine 2020;15:17-29. [PMID: 32021162 DOI: 10.2147/IJN.S214349] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 18 |
Krężel W, Rühl R, de Lera AR. Alternative retinoid X receptor (RXR) ligands. Mol Cell Endocrinol 2019;491:110436. [PMID: 31026478 DOI: 10.1016/j.mce.2019.04.016] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 11.8] [Reference Citation Analysis]
|
| 19 |
Colin M, Delporte C, Janky R, Lechon AS, Renard G, Van Antwerpen P, Maltese WA, Mathieu V. Dysregulation of Macropinocytosis Processes in Glioblastomas May Be Exploited to Increase Intracellular Anti-Cancer Drug Levels: The Example of Temozolomide. Cancers (Basel) 2019;11:E411. [PMID: 30909495 DOI: 10.3390/cancers11030411] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
|
